AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1592970
Drug: Dentifrice with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentifrice with 2500 micrograms F/g
Trial: 1592970
Drug: Dentifrice with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentifrice with 0 micrograms F/g (control)
Trial: 1592970
Drug: Fluoride-containing dentifrices
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-containing dentifrices (1000, 1500, 2500 micrograms F/g)
Trial: 6329092
Drug: pivmecillinam 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivmecillinam 400 mg every 6 h for 5 days
Trial: 6329092
Drug: ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ampicillin 500 mg every 6 h for 5 days
Trial: 6329092
Drug: pivmecillinam 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivmecillinam 400 mg every 6 h for 5 days (excluding resistant strains)
Trial: 6329092
Drug: ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ampicillin 500 mg every 6 h for 5 days (excluding resistant strains)
Trial: 6329092
Drug: pivmecillinam 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivmecillinam 400 mg every 6 h for 5 days (susceptible strains)
Trial: 6329092
Drug: ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ampicillin 500 mg every 6 h for 5 days (susceptible strains)
Trial: 30799839
Drug: Osteopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic treatment coupled with lactation consultation
Trial: 22244049
Drug: Iferanserin 10
RxNorm normalized name: Iferanserin
DrugBank: Iferanserin (DB11686)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iferanserin 10 mg BID
Trial: 27547421
Drug: Voglibose 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose 0.2 mg three times a day
Trial: 11958305
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous insulin infusion with dextrose 5%‐based cardioplegic solution
Trial: 11958305
Drug: Sliding scale
RxNorm normalized name: wing scale pollen extract
DrugBank: Atriplex canescens pollen (DB10767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sliding scale insulin treatment with normal saline 0.9%‐based cardioplegic solution
Trial: 1356117
Drug: Budesonide (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (0.4 mg at 8 AM and 8 PM)
Trial: 1356117
Drug: Bambuterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol (20 mg at 8 PM)
Trial: 30189251
Drug: Topical postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical postoperative tobramycin-dexamethasone
Trial: 26659113
Drug: Treatment-as-usual (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (control group, n=32)
Trial: 24781441
Drug: Olanzapine long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine long-acting injection (405 mg/4 weeks)
Trial: 24781441
Drug: Oral olanzapine
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral olanzapine (10 mg/d)
Trial: 22613240
Drug: Circuit class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circuit class therapy with heart rate monitor feedback
Trial: 22613240
Drug: Circuit class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circuit class therapy without heart rate monitor feedback (Control)
Trial: 17349034
Drug: Oral treatment
RxNorm normalized name: Other agents for local oral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral treatment for community acquired pneumonia
Trial: 17349034
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) treatment for community acquired pneumonia
Trial: 11323149
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg imipramine
Trial: 2161692
Drug: hPTH 1‐38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH 1‐38 (400 IU/day subcutaneous injection)
Trial: 2161692
Drug: hPTH 1‐38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH 1‐38 (0.5 U/kg/h intravenous infusion)
Trial: 2161692
Drug: hPTH 1‐38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH 1‐38 (intermittent treatment)
Trial: 2161692
Drug: hPTH 1‐38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH 1‐38 therapy
Trial: 2161692
Drug: hPTH 1‐38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH 1‐38 treatment
Trial: 23889806
Drug: Paricalcitol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (2 μg/day)
Trial: 21827773
Drug: Gallic acid
RxNorm normalized name: gallic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallic acid (GA) supplementation (12.8 mg/person/d) for three days
Trial: 14709514
Drug: Different facemasks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different facemasks used for aerosol medication delivery
Trial: 9228352
Drug: Albuterol solution,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol solution, 5 mg via nebulizer (Puritan‐Bennett Raindrop) impelled with oxygen at 8 L/min
Trial: 9228352
Drug: Albuterol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol, 400 microg via CFCMDI attached to a 145‐mL valved aerosol holding chamber (Aerochamber)
Trial: 9228352
Drug: Albuterol powder,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol powder, 400 microg by Rotahaler
Trial: 8028563
Drug: embovin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: embovin (10 mg/kg)
Trial: 8028563
Drug: combatrin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combatrin (10 mg/kg)
Trial: 29475446
Drug: n-3 LCPUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 LCPUFA supplements
Trial: 27456448
Drug: Intensive physiotherapy
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive physiotherapy (three times daily)
Trial: 27456448
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care physiotherapy (daily)
Trial: 25573904
Drug: Ritonavir powder
RxNorm normalized name: ritonavir Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir powder formulation in water under fasting, moderate-fat or high-fat conditions
Trial: 25573904
Drug: Ritonavir powder
RxNorm normalized name: ritonavir Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir powder formulation in chocolate milk or pudding under moderate-fat conditions
Trial: 25573904
Drug: Ritonavir oral
RxNorm normalized name: ritonavir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir oral solution under moderate-fat conditions
Trial: 25573904
Drug: Ritonavir powder
RxNorm normalized name: ritonavir Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir powder formulation in infant formula or apple sauce under moderate-fat conditions
Trial: 16248249
Drug: Integrative traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrative traditional and Western medicine (conventional Western medicine combined with Chinese compound recipe)
Trial: 16248249
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicine alone
Trial: 9715310
Drug: Picrorhiza kurroa
RxNorm normalized name: PICRORHIZA KURROA ROOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picrorhiza kurroa (Pk) root powder 375 mg three times a day for 2 weeks
Trial: 6828609
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of caffeine
Trial: 6828609
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose of caffeine
Trial: 6828609
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of caffeine
Trial: 24615500
Drug: Everolimus (EVE)
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus (EVE) 10 mg/day + Exemestane (EXE) 25 mg/day
Trial: 24615500
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) + Exemestane (EXE) 25 mg/day
Trial: 19670432
Drug: microS (MRX‐801)
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: microS (MRX‐801) infusion over 90 minutes (Cohort 1, 1.4ml)
Trial: 19670432
Drug: microS (MRX‐801)
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: microS (MRX‐801) infusion over 90 minutes (Cohort 2, 2.8ml)
Trial: 19670432
Drug: microS (MRX‐801)
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: microS (MRX‐801) infusion over 90 minutes (Cohort 1)
Trial: 19670432
Drug: microS (MRX‐801)
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: microS (MRX‐801) infusion over 90 minutes (Cohort 2)
Trial: 16140896
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg riboflavin + 20 mg iron (n = 83)
Trial: 16140896
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zinc (n = 83)
Trial: 16140896
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg riboflavin (control, n = 82)
Trial: 12151469
Drug: iloprost (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iloprost (2.5 or 5.0 microg, six or nine times per day; median inhaled dose, 30 microg per day)
Trial: 9935128
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 100 mg/d orally on days 1-10 of the menstrual cycle
Trial: 9935128
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg orally twice daily
Trial: 9935128
Drug: Triptorelin 3.75
RxNorm normalized name: triptorelin 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin 3.75 mg IM every 28 days
Trial: 7486235
Drug: E5510 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5510 4 mg
Trial: 7486235
Drug: E5510 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5510 2 mg
Trial: 9262254
Drug: Aspirin 324
RxNorm normalized name: aspirin 324 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 324 mg
Trial: 2248075
Drug: Moclobemide (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (150-300 mg daily)
Trial: 2248075
Drug: Tranylcypromine (15-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranylcypromine (15-30 mg daily)
Trial: 25399316
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (250 mg capsules every 8 h)
Trial: 25399316
Drug: Ginger (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (250 mg capsules every 6 h)
Trial: 24512486
Drug: Octreotide 100
RxNorm normalized name: 1 ML octreotide 100 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 100 μg sc
Trial: 24512486
Drug: Control (before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (before administration of octreotide)
Trial: 19346521
Drug: Non-ARB-based pharmacotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ARB-based pharmacotherapy
Trial: 17277998
Drug: Aspirin (81-325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81-325 mg daily for at least a week)
Trial: 17277998
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg daily for at least 3 days)
Trial: 11809123
Drug: nabumetone (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nabumetone (1000 mg/day)
Trial: 11809123
Drug: diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: diclofenac sodium (75 mg/day)
Trial: 3043571
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml prilocaine 1.5%
Trial: 3043571
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml bupivacaine 0.375%
Trial: 3043571
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml prilocaine 1% + 20 ml bupivacaine 0.5%
Trial: 3043571
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml prilocaine 2% + 20 ml bupivacaine 0.5%
Trial: 3043571
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml prilocaine 2% + 20 ml bupivacaine 0.375%
Trial: 29033547
Drug: Tablet formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet formulation of tacrolimus
Trial: 8888665
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 400 IU daily
Trial: 17152732
Drug: Mildronate 500
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mildronate 500 mg/day
Trial: 17152732
Drug: Traditional basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional basal therapy
Trial: 14747052
Drug: Second-line hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second-line hormonal therapy using ketoconazole and hydrocortisone
Trial: 14747052
Drug: Docetaxel and
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel and estramustine combination chemotherapy
Trial: 9351755
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol 200 microg every 3 hours for a maximum of five doses in the first 24 hours
Trial: 9351755
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 200 microg every 3 hours for a maximum of five doses in the first 24 hours
Trial: 31994364
Drug: 10 mL/kg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL/kg/h rate 5% Dextrose infusion preoperatively for 30 minutes, followed by Ringer's lactate until the end of surgery
Trial: 31994364
Drug: 10 mL/kg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL/kg/h rate of Ringer's lactate preoperatively for 30 minutes, followed by 5% Dextrose during the operation
Trial: 31994364
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate solution infusion at a rate of 10 mL/kg/h preoperatively and intraoperatively
Trial: 27004290
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) gel plus bovine-derived xenograft
Trial: 27004290
Drug: Bovine-derived xenograft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine-derived xenograft without PRP gel
Trial: 17996409
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release formulation of metformin hydrochloride
Trial: 17996409
Drug: Extended release
RxNorm normalized name: Tylenol Extended Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended release formulation of metformin hydrochloride
Trial: 15714177
Drug: Calcium (400
RxNorm normalized name: calcium carbonate 160 mg calcium (400 mg) ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (400 mg daily)
Trial: 15714177
Drug: Calcium (400
RxNorm normalized name: calcium carbonate 160 mg calcium (400 mg) ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (400 mg daily) + Vitamin D3 (25,000 IU monthly)
Trial: 12890859
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual care: NSAIDs, muscle relaxants, paracetamol, back exercises)
Trial: 8429117
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg bid
Trial: 4059297
Drug: triletide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triletide (1.5 g/day)
Trial: 4059297
Drug: antacids (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antacids (0.8 g/day each of aluminium hydroxide and magnesium hydroxide)
Trial: 4059297
Drug: triletide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triletide (1.5 g/day) in combination with antacids
Trial: 30824206
Drug: Photobiomodulation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation treatment
Trial: 28718728
Drug: Clofarabine (CIA)
RxNorm normalized name: Clofarabine
DrugBank: Clofarabine (DB00631)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Clofarabine (CIA) 15 mg/m2
Trial: 27112311
Drug: Microenema with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microenema with phenobarbital tablets crushed and suspended in 20 mL of tap water (MC-20)
Trial: 27112311
Drug: Microenema with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microenema with phenobarbital tablets crushed and suspended in 6 mL of tap water (MC-6)
Trial: 21805307
Drug: Prebiotic (mannanoligosaccharide)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic (mannanoligosaccharide) 4 g/calf/day
Trial: 20080837
Drug: Diiodothyropropionic acid
RxNorm normalized name: 3,5-diiodothyropropionic acid
DrugBank: 3,5-diiodothyropropionic acid (DB12629)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diiodothyropropionic acid (DITPA) at escalating doses (90 to 180, 270, and 360 mg/d)
Trial: 27225602
Drug: Treadmill exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treadmill exercise program (walking on a treadmill with fixed 0% grade, 3 times weekly for 48 weeks, first 12 weeks supervised, remaining 36 weeks unsupervised)
Trial: 27225602
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (encouraged to walk twice a week for 45 minutes and received standard health recommendations)
Trial: 19756774
Drug: Aprepitant (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (125 mg PO, ondansetron 32 mg IV, dexamethasone 12 mg day 1; aprepitant 80 mg days 2-3; dexamethasone 8 mg qd days 2-4)
Trial: 19756774
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ondansetron 32 mg IV, dexamethasone 20 mg PO day 1; dexamethasone 8 mg bid days 2-4)
Trial: 12631089
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g vitamin C
Trial: 12631089
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g vitamin C (healthy subjects)
Trial: 10973867
Drug: Oral salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral salbutamol (five doses of 4 mg)
Trial: 10973867
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (two doses of 100 microgram)
Trial: 10973867
Drug: Maximum dosage
RxNorm normalized name: Maximum-H
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Maximum dosage of inhaled salbutamol (1600 microgram in 24 h, 800 microgram in the last 4 h)
Trial: 8836892
Drug: Lymphoblastoid IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphoblastoid IFN alpha 3 or 5 MU three times a week for 6 or 12 months (total dosage 216‐720 MU)
Trial: 1592888
Drug: Metyrapone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metyrapone (30 mg/kg body weight) administered at midnight
Trial: 19489488
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine Nicardipine
Trial: 18681090
Drug: Indacaterol 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 400 microg via single-dose dry powder inhaler (SDDPI)
Trial: 14506028
Drug: High-dose azithromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose azithromycin (20 mg/kg once a day for 3 days)
Trial: 14506028
Drug: High-dose amoxicillin-clavulanate
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose amoxicillin-clavulanate (90 mg/kg divided twice a day for 10 days)
Trial: 14506028
Drug: High-dose azithromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose azithromycin
Trial: 14506028
Drug: High-dose amoxicillin-clavulanate
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose amoxicillin-clavulanate
Trial: 8678516
Drug: Leucovorin (LV,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucovorin (LV, 30 mg/body) + 5‐fluorouracil (5‐FU 500 ‐ 750 mg/body) administered intravenously